Propanc Biopharma, Inc.
Propanc Biopharma, Inc. (PPCB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PPCB · as of Jun 9, 2026
Key Statistics
Explore Propanc Biopharma, Inc. Data
ppcb stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
ppcb competitorsPPCB
CLCS
GLABF
HOOK
IMUC
PRVCFStock Performance
Full HistoryAbout Propanc Biopharma, Inc.
Propanc Biopharma, Inc. (PPCB) is an Australian biopharmaceutical firm dedicated to developing innovative treatments for various cancers, with a particular focus on pancreatic, ovarian, and colorectal…
what is propanc biopharma, inc. · ppcb stock overview · propanc biopharma, inc. company profile · who is propanc biopharma, inc. ceo · ppcb NASDAQ · propanc biopharma, inc. headquarters · propanc biopharma, inc. business segments
About Stock Overview & Key Data
Propanc Biopharma, Inc. (PPCB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 12, 2012. As of the latest trading session, PPCB stock price is $1.42, with a market capitalization of $1.2M. The stock has returned -99.23% over the past 12 months and -89.20% year-to-date.
In fiscal year 2025, Propanc Biopharma, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Propanc Biopharma, Inc. (PPCB) stock price is $1.42. The stock is traded on NASDAQ under the ticker symbol PPCB. The 52-week range is $1.31 – $270.25.